Anti-TNF in Rheumatic Diseases: Inventory and Outlook
With an increasing number of biosimilars receiving regulatory approval, the treatment landscape for rheumatic diseases is evolving. Healthcare professionals (HCP) are being presented with an expanding armamentarium of treatment options that can increase patient access to effective biologic therapies...
Main Author: | Syneos Health |
---|---|
Format: | Article |
Language: | English |
Published: |
European Medical Journal
2018-07-01
|
Series: | European Medical Journal Rheumatology |
Subjects: | |
Online Access: | https://www.emjreviews.com/rheumatology/symposium/anti-tnf-in-rheumatic-diseases-inventory-and-outlook/ |
Similar Items
-
Recent Advances in the Rheumatic Fever and Rheumatic Heart Disease Continuum
by: Joselyn Rwebembera, et al.
Published: (2022-01-01) -
Global research priorities in rheumatic fever and rheumatic heart disease
by: Carapetis Jonathan, et al.
Published: (2011-01-01) -
"SURVEY OF PREVALENCE RATE OF RHEUMATIC FEVER AND RHEUMATIC HEART DISEASE AMONG SCHOOL CHILDREN IN TEHRAN"
by: M. Nadimi., et al.
Published: (1973-06-01) -
The macrophages in rheumatic diseases
by: Laria A, et al.
Published: (2016-02-01) -
Rheumatic fever and rheumatic heart disease: Where are we now in South Africa?
by: Mark E. Engel, et al.
Published: (2017-04-01)